Evidence map›Paper›PMID 36958755›Full record

ReviewInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2023

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.

Vesna Kesic, Xavier Carcopino, Mario Preti, Pedro Vieira-Baptista, Federica Bevilacqua, Jacob Bornstein, Cyrus Chargari, Maggie Cruickshank, Emre Erzeneoglu, Niccolò Gallio and 12 more

Open access · hybridAbstract readReviewConsensus Statement
In one paragraph

Review in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Short-term efficacy and safety of COFrontiers in medicine · 2026
    Article
  12. Observational
  13. Clinical efficacy, safety and prognostic factors of photodynamic therapy for human papillomavirus infection with vaginal squamous intraepithelial lesion.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Article
  14. Marital status as an independent prognostic factor for survival in women with vaginal cancer: evidence from the SEER database analysis.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2025
    Observational
  15. Human Papillomavirus: An Old New History.Pathogens (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 16 institutions in 12 countries.

Vesna KesicMedical Faculty, University of Belgrade, Clinic of Obstetrics and Gynecology, University Clinical Center of Serbia, Belgrade, Serbia vek1@mts.rs.ORCID 0000-0002-3513-7192
Xavier CarcopinoDepartment of Obstetrics and Gynaecology, Hôpital Nord, APHM, Aix-Marseille University (AMU), Univ Avignon, CNRS, IRD, IMBE UMR 7263, 13397, Marseille, France.
Mario PretiDepartment of Surgical Sciences, University of Torino, Torino, Italy.ORCID 0000-0002-1573-3114
Pedro Vieira-BaptistaLower Genital Tract Unit Centro Hospitalar de São João, Porto, Portugal.ORCID 0000-0001-5335-6770
Federica BevilacquaDepartment of Surgical Sciences, University of Torino, Torino, Italy.
Jacob BornsteinGalilee Medical Center and Azrieli Faculty of Medicine, Bar-Ilan, Israel.
Cyrus ChargariDepartment of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.ORCID 0000-0003-0119-3695
Maggie CruickshankAberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK.
Emre ErzeneogluFaculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Hacettepe University, Ankara, Turkey.
Niccolò GallioDepartment of Surgical Sciences, University of Torino, Torino, Italy.
Murat GultekinDivision of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Hacettepe University Faculty of Medicine, Ankara, Turkey.ORCID 0000-0002-4221-4459
Debra HellerRutgers New Jersey Medical School, Newark, New Jersey, USA.
Elmar JouraDepartment of Gynecology and Gynecologic Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Maria KyrgiouSurgery and Cancer - West London Gynecological Cancer Center, IRDB, Department of Gut, Metabolism & Reproduction-Surgery & Cancer, Imperial College London, London, UK.
Tatjana MadićClinic for Obstetrics and Gynecology, University Clinical Center of Serbia, Belgrade, Serbia.
François PlanchampClinical Research Unit, Institut Bergonie, Bordeaux, France.ORCID 0000-0002-8709-0410
Sigrid RegauerDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Olaf ReichDepartment of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
Bilal Esat TemizFaculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Hacettepe University, Ankara, Turkey.
Linn WoelberDepartment of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
Jana ZodzikaDepartment of Obstetrics and Gynaecology Rīga Stradiņš University, Riga, Latvia.
Colleen StockdaleDepartment of Obstetrics & Gynecology, University of Iowa, Iowa City, Iowa, USA.
Hacettepe University · TRUniversity of Turin · ITMedical University of Graz · ATCentre National de la Recherche Scientifique · FRComprehensive Cancer Center Vienna · ATHospital de São João · PTImperial College Healthcare NHS Trust · GBInstitut Bergonié · FRInstitut Gustave Roussy · FRRiga Stradiņš University · LVRutgers, The State University of New Jersey · USUniversität Hamburg · DEUniversity of Aberdeen · GBUniversity of Belgrade · RSUniversity of Iowa · USWestern Galilee Hospital · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) developed consensus statements on pre-invasive vulvar lesions in order to improve the quality of care for patients with vaginal intraepithelial neoplasia (VaIN). The management of VaIN varies according to the grade of the lesion: VaIN 1 (low grade vaginal squamous intraepithelial lesions (SIL)) can be subjected to follow-up, while VaIN 2-3 (high-grade vaginal SIL) should be treated. Treatment needs individualization according to the patient's characteristics, disease extension and previous therapeutic procedures. Surgical excision is the mainstay of treatment and should be performed if invasion cannot be excluded. Total vaginectomy is used only in highly selected cases of extensive and persistent disease. Carbon dioxide (CO

Indexed as

Carcinoma in SituPapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsVaginal NeoplasmsColposcopyFemaleHumansImiquimodPregnancyQuality of LifeRetrospective StudiesImiquimodBrachytherapySurgical Procedures, OperativeVaginal NeoplasmsVulvar and Vaginal Cancer

Identifiers

PMID36958755
PMCPMC10086489
OpenAlexW4360612108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.